GPR 119 agonists (iNovacia)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameGPR 119 agonists (iNovacia)
Drug Alias NameG-protein coupled receptor 119 agonists (Swedish Orphan Biovitrum/iNovacia AB)GPR 119 agonists (Biovitrum)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlucose-dependent insulinotropic receptor agonists
TargetsGlucose-dependent insulinotropic receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSwedish Orphan Biovitrum Ab (Publ)
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesiNovacia ABSwedish Orphan Biovitrum Ab (Publ)
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A